Changes in adiponectin expression in acute myocardial infarction rats and the significance of bisoprolol intervention

Canadian Journal of Physiology and Pharmacology

Volumn 89, Issue 2, 2011, Pages 109-115

  Zhang, Song ^a,c,d   He, Ben ^a   Goldstein, Steven ^b   Ge, Junbo ^c   Wang, Zuyue ^b   Ruiz, George ^b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b WASHINGTON HOSPITAL CENTER   (United States)

^c FUDAN UNIVERSITY   (China)

^d Zhejiang Province Hospital   (China)

Author keywords

Adiponectin; Bisoprolol; Immunohistochemistry; Myocardial infarction; Protein expression; Rat; Rt pcr

Indexed keywords

ADIPONECTIN; BISOPROLOL; MESSENGER RNA;

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HEART MUSCLE; IMMUNOHISTOCHEMISTRY; NONHUMAN; OPTIMAL DRUG DOSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT;

ADIPONECTIN; ANIMALS; BISOPROLOL; FEMALE; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; MYOCARDIAL INFARCTION; MYOCARDIUM; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 79953085325     PISSN: 00084212     EISSN: 12057541     Source Type: Journal    
DOI: 10.1139/Y10-113     Document Type: Article

References (26)

1. Arita, Y., Kihara, S., Ouchi, N., Takahashi, M., Maeda, K., Miyagawa, J., et al. 1999. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun. 257(1): 79-83. doi:10.1006/bbrc.1999.0255. PMID:10092513.
2. Cavusoglu, E., Ruwende, C., Chopra, V., Yanamadala, S., Eng, C., Clark, L.T., et al. 2006. Adiponectin is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction in patients presenting with chest pain. Eur. Heart J. 27(19): 2300-2309. doi:10.1093/eurheartj/ehl153. PMID:16864609.
3. Chandran, M., Phillips, S.A., Ciaraldi, T., and Henry, R.R. 2003. Adiponectin: more than just another fat cell hormone? Diabetes Care, 26(8): 2442-2450. doi:10.2337/diacare.26.8.2442. PMID: 12882876.
4. Dalla Libera, L., Ravara, B., Gobbo, V., Danieli Betto, D., Germinario, E., Angelini, A., and Vescovo, G. 2005. Skeletal muscle myofibrillar protein oxidation in heart failure and the protective effect of Carvedilol. J. Mol. Cell. Cardiol. 38(5): 803-807. doi:10.1016/j.yjmcc.2005.02.023. PMID:15850574.
5. Efstathiou, S.P., Tsioulos, D.I., Tsiakou, A.G., Gratsias, Y.E., Pefanis, A.V., and Mountokalakis, T.D. 2005. Plasma adiponec-tin levels and five-year survival after first-ever ischemic stroke. Stroke, 36(9): 1915-1919. doi:10.1161/01.STR.0000177874. 29849.f0. PMID:16109902.
6. Fasshauer, M., Klein, J., Neumann, S., Eszlinger, M., and Paschke, R. 2001. Adiponectin gene expression is inhibited by β-adrener-gic stimulation via protein kinase A in 3T3-L1 adipocytes. FEBS Lett. 507(2): 142-146. doi:10.1016/S0014-5793(01) 02960-X. PMID:11684087.
7. Havel, P.J. 2004. Update on adipocyte hormones: regulation of energy balance and carbohydrate/lipid metabolism. Diabetes, 53(Suppl 1): S143-S151. doi:10.2337/diabetes.53.2007.S143. PMID:14749280.
8. Hotta, K., Funahashi, T., Arita, Y., Takahashi, M., Matsuda, M., Okamoto, Y., et al. 2000. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler. Thromb. Vasc. Biol. 20(6): 1595-1599. PMID: 10845877.
9. Kato, H., Kashiwagi, H., Shiraga, M., Tadokoro, S., Kamae, T., Ujiie, H., et al. 2006. Adiponectin acts as an endogenous antithrombotic factor. Arterioscler. Thromb. Vasc. Biol. 26(1): 224-230. doi:10. 1161/01.ATV.0000194076.84568.81. PMID:16269667.
10. Kitaoka, H., Kubo, T., Okawa, M., Yamasaki, N., Matsumura, Y., Nishinaga, M., and Doi, Y.L. 2010. Plasma adiponectin levels and left ventricular remodeling in hypertrophic cardiomyopathy. Int. Heart J. 51(1): 51-55. doi:10.1536/ihj.51.51. PMID: 20145352.
11. Kojima, S., Funahashi, T., Sakamoto, T., Miyamoto, S., Soejima, H., Hokamaki, J., et al. 2003. The variation of plasma concentrations of a novel, adipocyte derived protein, adiponectin, in patients with acute myocardial infarction. Heart, 89(6): 667. doi:10.1136/heart.89.6.667. PMID:12748233.
12. Maeda, K., Okubo, K., Shimomura, I., Funahashi, T., Matsuzawa, Y., and Matsubara, K. 1996. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem. Biophys. Res. Commun. 221(2): 286-289. doi:10.1006/bbrc.1996.0587. PMID:8619847.
13. Matsubara, M., Namioka, K., and Katayose, S. 2003. Decreased plasma adiponectin concentrations in women with low-grade C-reactive protein elevation. Eur. J. Endocrinol. 148(6): 657-662. doi:10.1530/eje.0.1480657. PMID:12773138.
14. Ouchi, N., Kihara, S., Arita, Y., Maeda, K., Kuriyama, H., Okamoto, Y., et al. 1999. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation, 100(25): 2473-2476. PMID:10604883.
15. Ouchi, N., Kihara, S., Arita, Y., Nishida, M., Matsuyama, A., Okamoto, Y., et al. 2001. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macro-phages. Circulation, 103(8): 1057-1063. PMID:11222466.
16. Piestrzeniewicz, K., Luczak, K., Komorowski, J., Maciejewski, M., Piechowiak, M., Jankiewicz-Wika, J., and Goch, J.H. 2007. Obesity and adiponectin in acute myocardial infarction. Cardiol J. 14(1): 29-36. PMID:18651432.
17. Piestrzeniewicz, K., Luczak, K., Maciejewski, M., and Drozdz, J. 2010. Low adiponectin blood concentration predicts left ventricular remodeling after ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. Cardiol J. 17(1): 49-56. PMID:20104457.
18. Piñeiro, R., Iglesias, M.J., Gallego, R., Raghay, K., Eiras, S., Rubio, J., et al. 2005. Adiponectin is synthesized and secreted by human and murine cardiomyocytes. FEBS Lett. 579(23): 5163-5169. doi:10.1016/j.febslet.2005.07.098. PMID:16140297.
19. Pischon, T., Girman, C.J., Hotamisligil, G.S., Rifai, N., Hu, F.B., and Rimm, E.B. 2004. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA, 291(14): 1730-1737. doi:10.1001/jama.291.14.1730. PMID:15082700.
20. Saito, K., Tobe, T., Minoshima, S., Asakawa, S., Sumiya, J., Yoda, M., et al. 1999. Organization of the gene for gelatin-binding protein (GBP28). Gene, 229(1-2): 67-73. doi:10.1016/S0378-1119(99)00041-4. PMID:10095105.
21. Sato, C., Yasukawa, Z., Honda, N., Matsuda, T., and Kitajima, K. 2001. Identification and adipocyte differentiation-dependent expression of the unique disialic acid residue in an adipose tissue-specific glycoprotein, adipo Q. J. Biol. Chem. 276(31): 28849-28856. doi:10.1074/jbc.M104148200. PMID:11382781.
22. Scherer, P.E., Williams, S., Fogliano, M., Baldini, G., and Lodish, H.F. 1995. A novel serum protein similar to C1q, produced exclusively in adipocytes. J. Biol. Chem. 270(45): 26746-26749. doi:10.1074/jbc.270.45.26746. PMID:7592907.
23. Shibata, R., Izumiya, Y., Sato, K., Papanicolaou, K., Kihara, S., Colucci, W.S., et al. 2007. Adiponectin protects against the development of systolic dysfunction following myocardial infarc-tion. J. Mol. Cell. Cardiol. 42(6): 1065-1074. doi:10.1016/j. yjmcc.2007.03.808. PMID:17499764.
24. Tao, L., Wang, Y., Gao, E., Zhang, H., Yuan, Y., Lau, W.B., et al. 2010. Adiponectin: an indispensable molecule in rosiglitazone cardioprotection following myocardial infarction. Circ. Res. 106(2): 409-417. doi:10.1161/CIRCRESAHA.109.211797. PMID:19940263.
25. Watanabe, K., Ohta, Y., Inoue, M., Ma, M., Wahed, M.I., Nakazawa, M., et al. 2001. Bisoprolol improves survival in rats with heart failure. J. Cardiovasc. Pharmacol. 38(Suppl 1): S55-S58. PMID:11811360.
26. Yoda-Murakami, M., Taniguchi, M., Takahashi, K., Kawamata, S., Saito, K., Choi-Miura, N.H., and Tomita, M. 2001. Change in expression of GBP28/adiponectin in carbon tetrachloride-admi-nistrated mouse liver. Biochem. Biophys. Res. Commun. 285(2): 372-377. doi:10.1006/bbrc.2001.5134. PMID:11444852.